11/19/2014 - 11:43 AM EST - Opsens Inc. : announced that it has been granted CE marking for OptoWire and OptoMonitor, which allows these Fractional Flow Reserve products for patients with coronary artery disease to be marketed in Europe, the world's second-largest market. Opsens Inc.
shares V.OPS are trading unchanged at $0.72.
